A Multi-Centre, Double-Blind, Randomised, Parallel Group, Placebo- Controlled and Active Controlled Phase III Study of the Efficacy and Safety of Quetiapine Fumarate Sustained Release (Seroquel SRTM) as Mono- Therapy in the Treatment of Adult Patients With Major Depressive Disorder
Phase of Trial: Phase III
Latest Information Update: 01 Jun 2011
At a glance
- Drugs Escitalopram; Quetiapine
- Indications Major depressive disorder
- Focus Therapeutic Use
- Acronyms AMBER
- Sponsors AstraZeneca
- 14 Dec 2007 Status changed from in progress to completed.
- 03 Jul 2007 Status change from recruiting to in progress.
- 04 Nov 2006 New trial record.